News Room

When Marshall Fisher recently reviewed the outline of his planned lecture series on global supply chain management at Wharton Business School which begins this month, he realised it required some extensive reworking. “I swallowed hard, decided to throw away the course and start again,” says Mr Fisher, professor of operations, information and decisions. He has since updated almost half his 13 scheduled classes with fresh examples linked to coronavirus. “I thought I just can’t teach the same course again. Every time you open the newspaper you see Covid and supply chains.”

The AI gold rush has been underway in the financial services industry for the past few years. According to the UK Financial Conduct Authority and the Bank of England, two-thirds of Britain’s financial services firms use some form of machine learning. Just over half have an R&D strategy to add even more to their AI capabilities. That strategy needs a well-developed ethical component.

“This work shows that you can improve the quality of life for children with asthma and you can reduce government spending by implementing these proactive interventions,” says lead author Julie Swann, department head and professor in the industrial and systems engineering department at North Carolina State University.

BRINK spoke to Julie Swann, a senior advisor to the CDC on the last national vaccine distribution in 2009 for the H1N1 flu vaccine. She is a professor at North Carolina State University and co-founder of the Center for Health and Humanitarian Systems at Georgia Tech.

This summer, nearly a third of a local manufacturing company’s workforce caught COVID-19. Spacecraft Components Corp. voluntarily shut down its North Las Vegas operation for two weeks in June after a handful of its 140 employees reported having the disease. Within weeks, approximately 40 employees tested positive for the coronavirus, the company’s controller said.